Navigation Links
Bionovo Announces Third Quarter 2011 Highlights and Financial Results
Date:11/10/2011

se)

-(28)3(39)(202)Total other income (expense)

2,298(35)3,967(56)6,068Net loss

$
(3,931)$
(4,627)$  (13,512)$  (13,408)$
(87,058)Basic and diluted net loss per common share

$
(0.07)$
(0.21)$
(0.27)$
(0.62)$
(6.22)Shares used in computing basic and diluted
net loss per share

54,56121,78550,93121,60714,005Bionovo, Inc.(A Development Stage Company)Consolidated Balance Sheets(in thousands, except share amounts)September 30,
2011December 31,
2010(unaudited)ASSETSCurrent assets:Cash and cash equivalents

$
,229$
2,638Short-term investments

6,846-Receivables

1449Prepaid expenses

937973Other current assets

842396Total current assets

9,8684,056Property and equipment, net

11,7606,647Patent pending, net

1,6311,259Other assets

7611,020Total assets

$
24,020$
2,982LIABILITIES AND SHAREHOLDERS’ EQUITYCurrent liabilities:Accounts payable

$
567$
55Accrued compensation and benefits

822901Current portion of lease obligations

1,0511,055Current portion of notes payable

840Warrant liability

8,0171,843Other current liabilities

1,791970Total current liabilities

12,2565,464Non-current portion of lease obligations

121836Non-current portion of notes payable

7581Total liabilities

12,4526,381Commitments and contingenciesShareholders’ equity:Preferred stock, $0.0001 par value; 10,000,000 shares authorized; none issued and outstanding

--Common stock $0.0001 par value, 340,000,000 shares authorized, 54,561,312 and 24,530,112 shares outstanding at September 30, 2011 and December 31, 2010, respectively

52Additional paid-in capital

98,62280,145Accumulated other comprehensive loss

(1)-Accumulated deficit

(87,058)(73,546)Total shareholders’ equity

11,5686,601Total liabilities and shareh
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Bionovo Initiates Menerba (MF101) Phase 3 Clinical Trial for Menopausal Hot Flashes
2. Bionovo to Present Tissue Selective Estrogen Receptor Modulators for Obesity at the 22nd Annual Meeting of the North American Menopause Society
3. Bionovo Announces an Additional 180 Day Period to Regain Compliance With Nasdaqs Bid Price Rule
4. CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results
5. Bionovo Announces Second Quarter 2011 Highlights and Financial Results
6. Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause
7. Bionovo to Announce First Quarter Financial Results on Wednesday, May 11, 2011
8. Bionovo Announces Enrollment Started in the Menerba (MF101) Phase 1 "Tolerability" Clinical Trial for Menopausal Hot Flushes
9. Bionovo Announces 2010 Highlights and Year-End Financial Results
10. Bionovo, Inc. to Announce Fourth Quarter Fiscal Year 2010 Financial Results on Tuesday, March 15, 2011
11. Bionovo to Present at the Cowen and Company 31st Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Texas , Sept. 4, 2015  Luminex Corporation ... present at the Morgan Stanley Global Healthcare Conference to ... Grand Hyatt Hotel in New York City ... at 11:40 a.m. Eastern time on Friday, September 18, ... accessed at Luminex Corporation,s website at http://www.luminexcorp.com . ...
(Date:9/4/2015)... 4, 2015 According to a ... Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis) by Procedure (Therapeutic Apheresis, ... - Global Forecast to 2020", published by MarketsandMarkets, the ... Billion by 2020, growing at a CAGR of 11.2% ... Browse 139 Tables and 45 F ...
(Date:9/4/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... upcoming Rodman & Renshaw 17 th Annual Global ... New York City .  Dr. Michael ... overview on September 9, 2015. Presentation ...
Breaking Medicine Technology:Luminex Corporation To Present At The Morgan Stanley Global Healthcare Conference 2Apheresis Market Worth 2.5 Billion USD by 2020 2Apheresis Market Worth 2.5 Billion USD by 2020 3Apheresis Market Worth 2.5 Billion USD by 2020 4Apheresis Market Worth 2.5 Billion USD by 2020 5Oramed to Present at the Rodman & Renshaw Global Investment Conference 2Oramed to Present at the Rodman & Renshaw Global Investment Conference 3
... 2011 Par Pharmaceutical Companies, Inc. (NYSE: PRX ... EST on Friday, January 6, 2012 at the Millennium Hotel, ... Executive Officer, Patrick G. LePore, and other members of the ... growth strategy, current products and pipelines, and business outlook to ...
... Calif., Dec. 5, 2011  Beyond Lucid Technologies, Inc., ... disaster management, and First Response industries, today announced ... the mHealth Summit, and the publication of a ... connect ambulances with hospitals via telemedicine. ...
Cached Medicine Technology:Beyond Lucid Technologies Advances Telemedicine for EMS Providers 2Beyond Lucid Technologies Advances Telemedicine for EMS Providers 3
(Date:9/4/2015)... ... September 04, 2015 , ... Mile High Connects today releases “First ... lack of funding for sidewalks, bike paths, and other vital supports severely limit access ... region spends billions of dollars to expand public transit, there’s very little support for ...
(Date:9/4/2015)... ... 2015 , ... After wearing the same uniforms for six seasons, the Sprayberry ... effort to assist the team, the Jones Agency, a locally owned insurance firm that ... for the new uniforms. , As is so often the case with high school ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... ... that CEREC technology is now available at CitiDent. CEREC is a newer method ... addition to saving time for patients by eliminating the need for multiple appointments, ...
(Date:9/4/2015)... ... 04, 2015 , ... The USC Eye Institute is proud to announce that ... Faculty, residents and staff are honored to have contributed to the success of ... ophthalmology residency program. Our faculty places a high priority on our educational programs in ...
(Date:9/4/2015)... ... September 04, 2015 , ... Steven ... South Glastonbury, Connecticut, has been selected for the Residential Award of Merit by ... and resiliency measures. Chosen from a highly competitive field of submissions, the net-zero ...
Breaking Medicine News(10 mins):Health News:Missed Connections in Metro Denver Transit 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:South Glastonbury Home Selected for Award by Connecticut Green Building Council 2
... study suggests that flaxseed lowers female hormone levels and may ... for thousands of years - the fibres to make linen ... rich in lignans, which resemble the female hormone oestrogen.// ... and lignans may lower levels by blocking oestrogen synthesis. Researchers ...
... experts from the Mayo Clinic in Rochester, Minnesota Vitamin E ... sufferers with hot flashes. Estrogen relieves hot flashes in ... cancer survivors because the hormone may stimulate breast cancer growth.// ... hot flashes and other symptoms of menopause, and is approved ...
... of Pittsburgh reveals that heredity has a central role in ... of the research explains that "the genetic influences play an ... ,During the research the families of 323 women ... disorder were analyzed, to compare with other group of 181 ...
... examination gives two distinct signs that signal heart failure. Generally ... many. But doctors at the Heart Failure Research Unit at ... a physical exam are highly relevant to heart failure.// ... are detected; a third heart sound, known as 'gallop', is ...
... A surgical technique to correct a blinding condition in premature ... with retinopathy in prematurity (ROP) have an abnormal growth of ... not treated , the condition can lead to legal blindness ... Cryotherapy, is employed in which a freezing probe is ...
... Researchers at massachusetts General Hospital (MGH), published a study-- HIV ... immune attack. But once these mutations occur they persist. ... displaying viral protein fragments on the surface. This is a ... that is generated depends on the ability to recognise the ...
Cached Medicine News:
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... the BE Series for top performance ... industry, education, laboratory, clean room, static ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... the BE Series for top performance ... industry, education, laboratory, clean room, static ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... the BE Series for top performance ... industry, education, laboratory, clean room, static ...
... with concave seats and large backrests ... like seats, backrests, armrests, and casters ... Series for top performance in a ... laboratory, clean room, static control, health ...
Medicine Products: